Voluntary Operational Update - Manufacturing and Supply Agreement for Senstend
Licence Agreement with Kobayashi for the Commercial Launch of Fortacin in Japan
Termination of Discloseable Transaction on Disposal of 25% Equity Interest in the Target Company
Discloseable Transaction - Disposal of 25% Equity Interest in the Target Company